Nurse Practitioner · Rancho Cucamonga, CA
NPI
1750820593
Since 2017
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
8692 9th St Unit 56
Rancho Cucamonga, CA, 91730
Phone (909) 600-8638
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$336K
831 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Danielle Noe prescribed most often to Medicare patients was Sevelamer Carbonate, with 79 prescriptions and refills. In total Danielle Noe wrote 831 Medicare prescriptions that cost $336K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-02-13.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Sevelamer Carbonate Generic | 79 | 149 | 36 | $19K |
| Prosol Parenteral Amino Acid 20% No.1 | 74 | 74 | Under 11 | $8,732 |
| Calcium Acetate Generic | 59 | 139 | 27 | $5,853 |
| Sevelamer Hcl Generic | 52 | 123 | 17 | $77K |
| Velphoro Sucroferric Oxyhydroxide | 47 | 55 | 11 | $104K |
| Clinolipid Fat Emulsion/Olive/Soy/Phospho | 44 | 44 | Under 11 | $14K |
| Midodrine Hcl Generic | 38 | 81 | 15 | $2,180 |
| Amlodipine Besylate Generic | 33 | 72 | 11 | $206 |
| Hydralazine Hcl Generic | 30 | 44 | Under 11 | $276 |
| Carvedilol Generic | 23 | 51 | 12 | $251 |
| Lisinopril Generic | 21 | 33 | Under 11 | $55.66 |
| Clonidine Hcl Generic | 18 | 36 | Under 11 | $161 |
| Auryxia Ferric Citrate | 18 | 20 | Under 11 | $27K |
| Lokelma Sodium Zirconium Cyclosilicate | 18 | 45 | Under 11 | $15K |
| Triamcinolone Acetonide Generic | 16 | 16 | Under 11 | $134 |
Brand drugs: 231 claims; generic drugs: 600 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Danielle Noe were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.